Summary:
- This article discusses a new study that has developed a novel drug delivery system using a type of nanoparticle called a "nanozyme." These nanozymes are able to target and deliver therapeutic drugs specifically to cancer cells, while avoiding healthy cells.
- The nanozymes are designed to be responsive to the acidic microenvironment of tumors, which triggers the release of the drug payload. This targeted delivery helps increase the efficacy of the cancer treatment while reducing side effects.
- The study demonstrates the potential of this nanozyme-based drug delivery system to improve cancer therapy, and the authors suggest it could be a promising approach for treating various types of cancer.